The use of cannabis as a mood stabilizer in bipolar disorder: Anecdotal evidence and the need for clinical research

被引:0
|
作者
Grinspoon, L [1 ]
Bakalar, JB [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
关键词
bipolar; cannabis; depression; lithium; mania; marijuana;
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The authors present case histories indicating that a number of patients find cannabis (marihuana) useful in the treatment of their bipolar disorder. Some used it to treat mania, depression, or both. They stated that it was more effective than conventional drugs, or helped relieve the side effects of those drugs. One woman found that cannabis curbed her manic rages; she and her husband have worked to make it legally available as a medicine. Others described the use of cannabis as a supplement to lithium (allowing reduced consumption) or for relief of lithium's side effects. Another case illustrates the fact that medical cannabis users are in danger of arrest, especially when children are encouraged to inform on parents by some drug prevention programs. An analogy is drawn between the status of cannabis today and that of lithium in the early 1950s, when its effect on mania had been discovered but there were no controlled studies. In the case of cannabis, the law has made such studies almost impossible, and the only available evidence is anecdotal. The potential for cannabis as a treatment for bipolar disorder unfortunately can not be fully explored in the present social circumstances.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 50 条
  • [1] Mood stabilizer combinations for bipolar disorder
    Lovell, RW
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06): : 980 - 980
  • [2] Lamotrigine as mood stabilizer in bipolar disorder
    Andersen, J
    Tvarno, K
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 (02) : 91 - 91
  • [3] Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement
    Gould, Todd D.
    Einat, Haim
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (06): : 825 - 831
  • [4] Mood stabilizer discontinuation in pregnant women with bipolar disorder
    Mazer-Poline, Carrie
    Rifkin, Arthur
    Geisler, Stephen
    Walch, Tina
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (05): : 646 - 647
  • [5] Changes in mood stabilizer prescription patterns in bipolar disorder
    Karanti, Alina
    Kardell, Mathias
    Lundberg, Ulrika
    Landen, Mikael
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 195 : 50 - 56
  • [6] Pharmacogenomics of anticonvulsant mood stabilizer response in bipolar disorder
    Biernacka, Joanna
    [J]. BIPOLAR DISORDERS, 2023, 25 : 42 - 42
  • [7] CLINICAL-EVIDENCE OF MITOCHONDRIAL INHERITANCE IN BIPOLAR MOOD DISORDER
    MCMAHON, FJ
    STINE, OC
    SIMPSON, SG
    DEPAULO, JR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 116 - 116
  • [8] Effects of mood stabilizer treatment on mood episode relapse and recurrence in bipolar disorder
    Ketter, T
    Suppes, T
    Goldberg, J
    Frye, M
    White, R
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S153 - S153
  • [9] Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
    Kuhns, Lauren
    Kroon, Emese
    Colyer-Patel, Karis
    Cousijn, Janna
    [J]. PSYCHOPHARMACOLOGY, 2022, 239 (05) : 1231 - 1249
  • [10] Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
    Lauren Kuhns
    Emese Kroon
    Karis Colyer-Patel
    Janna Cousijn
    [J]. Psychopharmacology, 2022, 239 : 1231 - 1249